145 related articles for article (PubMed ID: 22939322)
1. Survival of patients with pathologic T0N+ oral and oropharyngeal cancer after neoadjuvant therapy and surgery: the minority report.
Perisanidis C; Sulzbacher I; Mittlböck M; Mitchell D; Czembirek C; Seemann R; Ewers R; Schopper C; Selzer E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):293-8. PubMed ID: 22939322
[TBL] [Abstract][Full Text] [Related]
2. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients.
Klug C; Wutzl A; Kermer C; Voracek M; Kornek G; Selzer E; Glaser C; Poeschl PW; Millesi W; Ewers R
Int J Oral Maxillofac Surg; 2005 Mar; 34(2):143-8. PubMed ID: 15695042
[TBL] [Abstract][Full Text] [Related]
3. The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery.
Kreppel M; Dreiseidler T; Rothamel D; Eich HT; Drebber U; Zöller JE; Scheer M
J Craniomaxillofac Surg; 2013 Jan; 41(1):22-7. PubMed ID: 22727901
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
[TBL] [Abstract][Full Text] [Related]
6. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
7. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379
[TBL] [Abstract][Full Text] [Related]
8. Quality of life 2-10 years after combined treatment for advanced oral and oropharyngeal cancer.
Klug C; Neuburg J; Glaser C; Schwarz B; Kermer C; Millesi W
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):664-9. PubMed ID: 12521326
[TBL] [Abstract][Full Text] [Related]
9. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
13. Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients.
Klug C; Berzaczy D; Voracek M; Nell C; Ploder O; Millesi W; Ewers R
J Craniomaxillofac Surg; 2009 Sep; 37(6):344-7. PubMed ID: 19525119
[TBL] [Abstract][Full Text] [Related]
14. Sequential therapy of advanced buccal mucosa squamous cell carcinoma: three-year outcome.
Lyu J; Li C; Wu Y; Wang R; Ren G; Guo W
J Oral Maxillofac Surg; 2014 Mar; 72(3):606-10. PubMed ID: 24342583
[TBL] [Abstract][Full Text] [Related]
15. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
16. Bilateral neck node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery.
Lim YC; Koo BS; Choi EC
Laryngoscope; 2007 Sep; 117(9):1576-80. PubMed ID: 17667136
[TBL] [Abstract][Full Text] [Related]
17. Combined surgery and postoperative radiotherapy for oropharyngeal squamous cell carcinoma in Korea: analysis of 110 cases.
Lim YC; Hong HJ; Baek SJ; Park JH; Kim GE; Lee CG; Lew DH; Lee WJ; Choi EC
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1099-105. PubMed ID: 18722091
[TBL] [Abstract][Full Text] [Related]
18. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Kovács AF; Schiemann M; Turowski B
J Craniomaxillofac Surg; 2002 Apr; 30(2):112-20. PubMed ID: 12069515
[TBL] [Abstract][Full Text] [Related]
19. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E
Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290
[TBL] [Abstract][Full Text] [Related]
20. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
